High-Density Lipoprotein Changes in Alzheimer’s Disease Are APOE Genotype-Specific
暂无分享,去创建一个
D. Harvey | C. DeCarli | D. Mungas | S. Farias | C. Lebrilla | J. Olichney | A. Zivkovic | Izumi Maezawa | Angela M. Zivkovic | Xinyu Tang | Brian V. Hong | Lee‐way Jin | Jingyuan Zheng | Joanne K. Agus | Kelsey Erickson | Joanne K Agus | Lee-Way Jin
[1] L. Schneider,et al. The small HDL particle hypothesis of Alzheimer’s disease , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[2] Jea Woo Kang,et al. Lipid-Based Nutrient Supplementation Increases High-Density Lipoprotein (HDL) Cholesterol Efflux Capacity and Is Associated with Changes in the HDL Glycoproteome in Children , 2021, ACS omega.
[3] H. Yassine,et al. Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases , 2021, Frontiers in Physiology.
[4] Jea Woo Kang,et al. Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins , 2021, Scientific Reports.
[5] P. Sachdev,et al. Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes , 2021, Translational Psychiatry.
[6] C. Cervellati,et al. Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis , 2021, Diagnostics.
[7] N. Rotllan,et al. Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia , 2021, Current Atherosclerosis Reports.
[8] Anonymous,et al. 2021 Alzheimer's disease facts and figures , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[9] K. Shimada,et al. The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation , 2021, Scientific Reports.
[10] D. Galimberti,et al. ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease[S] , 2019, Journal of Lipid Research.
[11] C. Wellington,et al. HDL from an Alzheimer's disease perspective , 2019, Current opinion in lipidology.
[12] M. Mimura,et al. The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up , 2019, Translational Psychiatry.
[13] A. Tall,et al. Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[14] S. Kashyap,et al. Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.
[15] Anna Gluba-Brzózka,et al. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk , 2017, Lipids in Health and Disease.
[16] Olga V. Demler,et al. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) , 2017, Circulation.
[17] D. Harvey,et al. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort , 2017, Alzheimer's & Dementia.
[18] K. Kotani,et al. The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[19] H. Chui,et al. ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease , 2016, Journal of the American Heart Association.
[20] D. Harvey,et al. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. , 2015, JAMA neurology.
[21] A. Khera,et al. HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.
[22] Michael Holzer,et al. Aging affects high-density lipoprotein composition and function , 2013, Biochimica et biophysica acta.
[23] D. Rader,et al. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? , 2012, Nature Medicine.
[24] S. Hama,et al. HDL functionality , 2012, Current opinion in lipidology.
[25] A. Cardona,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[26] G. Pawelec,et al. Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease , 2012, Mechanisms of Ageing and Development.
[27] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[28] P. Visser,et al. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[29] Robert L Wilensky,et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.
[30] M. Linton,et al. Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease* , 2010, The Journal of Biological Chemistry.
[31] C. DeCarli,et al. Recruitment of a Community-based Cohort for Research on Diversity and Risk of Dementia , 2010, Alzheimer disease and associated disorders.
[32] A. Smith,et al. Predicting the time of conversion to MCI in the elderly , 2009, Neurology.
[33] A. Kontush,et al. Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[34] N. Brot,et al. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I , 2008, Proceedings of the National Academy of Sciences.
[35] G. Kaysen. Metabolic syndrome and renal failure: similarities and differences. , 2006, Panminerva Medica (Testo stampato).
[36] Paul K Crane,et al. Spanish and English Neuropsychological Assessment Scales (SENAS): further development and psychometric characteristics. , 2004, Psychological assessment.
[37] D. Zaitchik,et al. Predicting conversion to Alzheimer disease using standardized clinical information. , 2000, Archives of neurology.
[38] B. Reed,et al. Development of psychometrically matched English and Spanish language neuropsychological tests for older persons. , 2000, Neuropsychology.
[39] S.-M. Kim,et al. Glycation impairs high-density lipoprotein function , 2000, Diabetologia.
[40] G. Siest,et al. Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆ , 2000, Neurobiology of Aging.
[41] C. DeCarli,et al. Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.
[42] J. Haines,et al. ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.
[43] B. Horwitz,et al. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.
[44] G. Ren,et al. Optimized negative-staining electron microscopy for lipoprotein studies. , 2013, Biochimica et biophysica acta.